Skip to content

Physiological effects of goal directed therapy (incorportating dopexamine infusion) in patients undergoing major surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN94850719
Enrollment
135
Registered
2007-01-29
Start date
2007-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major abdominal surgery Surgery Abdominal surgery

Interventions

In addition to maintenance fluid, control group patients will receive additional 250 ml fluid challenges with colloid solution as required, to achieve a sustained rise in central venous pressure. In

Sponsors

Queen Mary's University of London (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients admitted to intensive care or high dependency unit following elective major abdominal surgery

Exclusion criteria

Exclusion criteria: 1. Refusal of consent 2. Concurrent lithium therapy 3. Acute myocardial ischaemia 4. Acute arrhythmias 5. Pregnancy 6. Patients receiving palliative treatment only 7. Weight less than 40 kg

Design outcomes

Primary

MeasureTime frame
Reduction in post-operative complication rates associated with the use of Goal Directed Therapy. Added as of 23/10/2007: Increase in tissue oxygenation associated with the use of Goal Directed Therapy.

Secondary

MeasureTime frame
1. Reduction in microvascular perfusion associated with the use of Goal Directed Therapy 2. Reduction in tissue oxygenation associated with the use of Goal Directed Therapy 3. Reduction in post-operative duration of hospital stay associated with the use of Goal Directed Therapy 4. Reduction in post-operative mortality associated with the use of Goal Directed Therapy

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026